Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Association between Diet and Multiple Sclerosis.
Asgharzadeh V, Seyyed Rezaei SA, Poor BM, Asgharzadeh M, Nobari HJ, Taghinejad Z, Kazemi A, Rashedi J. Asgharzadeh V, et al. Among authors: poor bm. Endocr Metab Immune Disord Drug Targets. 2023 Nov 6. doi: 10.2174/0118715303247891231023070031. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37933212
False-Positive Mycobacterium tuberculosis Detection: Ways to Prevent Cross-Contamination.
Asgharzadeh M, Ozma MA, Rashedi J, Poor BM, Agharzadeh V, Vegari A, Shokouhi B, Ganbarov K, Ghalehlou NN, Leylabadlo HE, Kafil HS. Asgharzadeh M, et al. Among authors: poor bm. Tuberc Respir Dis (Seoul). 2020 Jul;83(3):211-217. doi: 10.4046/trd.2019.0087. Epub 2020 Apr 29. Tuberc Respir Dis (Seoul). 2020. PMID: 32578410 Free PMC article.
IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest Iran.
Asgharzadeh M, Najafi-Ghalehlou N, Poor BM, Asgharzadeh V, Pourostadi M, Vegari A, Kafil HS, Fadaee M, Farhoudi M, Rashedi J. Asgharzadeh M, et al. Among authors: poor bm. Endocr Metab Immune Disord Drug Targets. 2021;21(3):520-525. doi: 10.2174/1871530320666200505123443. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32368988
Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran.
Asgharzadeh M, Jigheh ZA, Kafil HS, Farhoudi M, Oskouei DS, Khaki-Khatibi F, Fadaee M, Vegari A, Asgharzadeh V, Najafi-Ghalelou N, Poor BM, Rashedi J. Asgharzadeh M, et al. Among authors: poor bm. Endocr Metab Immune Disord Drug Targets. 2020;20(7):1110-1116. doi: 10.2174/1871530320666200309142541. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32148206
Tuberculosis and Diabetes Mellitus in Northwest of Iran.
Ozma MA, Rashedi J, Poor BM, Vegari A, Asgharzadeh V, Kafil HS, Kazemi A, Sahebi L, Asgharzadeh M. Ozma MA, et al. Among authors: poor bm. Infect Disord Drug Targets. 2020;20(5):667-671. doi: 10.2174/1871526519666190715142100. Infect Disord Drug Targets. 2020. PMID: 31322073
HIV/AIDS in Iran.
Baghi HB, Aghazadeh M, Rashedi J, Poor BM. Baghi HB, et al. Clin Infect Dis. 2017 Mar 15;64(6):820-821. doi: 10.1093/cid/cix006. Clin Infect Dis. 2017. PMID: 28077519 No abstract available.
Sexual Disorders in Men and Iranian Ancient Medicine.
Pourmand M, Rashedi J, Poor BM, Asgharzadeh M, Moosavi SS. Pourmand M, et al. Arch Sex Behav. 2016 Oct;45(7):1599-600. doi: 10.1007/s10508-016-0794-3. Epub 2016 Jul 7. Arch Sex Behav. 2016. PMID: 27388510 No abstract available.